Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

2.2% minoxidil gel effectively and safely treats alopecia areata.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

Baricitinib is effective and safe for treating severe alopecia areata.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Aumolertinib effectively controls lung cancer and improves quality of life.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Baricitinib helps alopecia areata and may improve psoriasis, but its effect on psoriatic arthritis is unclear.

Topical treatment SM04554 safely promotes hair growth in male baldness.

Different people with severe hair loss respond to baricitinib treatment at different times, with some showing improvement early, some gradually, and others later.

The treatment showed promising hair regrowth in advanced-stage hair loss.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Shorter alopecia areata episodes lead to better baricitinib treatment outcomes.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Regional prescribing of ritlecitinib mostly follows national guidance, but psychological assessments and consistent scoring need improvement.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Procyanidin B-2 lotion might help men grow thicker hair without side effects.

Peripheral blood alive cell treatment is effective and safe for treating hair loss.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated for treating androgenetic alopecia.